|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011.
|
|
2
|
Yang L, Parkin DM, Ferlay J, Li L and Chen
Y: Estimates of cancer incidence in China for 2000 and projections
for 2005. Cancer Epidemiol Biomarkers Prev. 14:243–250. 2005.
|
|
3
|
Esposito L, Conti D, Ailavajhala R, Khalil
N and Giordano A: Lung Cancer: Are we up to the Challenge? Curr
Genomics. 11:513–518. 2010.
|
|
4
|
Alberg AJ, Ford JG and Samet JM; American
College of Chest Physicians. Epidemiology of lung cancer: ACCP
evidence-based clinical practice guidelines (2nd edition). Chest.
132(3 Suppl): 29S–55S. 2007.
|
|
5
|
Song SW, Fuller GN, Zheng H and Zhang W:
Inactivation of the invasion inhibitory gene IIp45 by alternative
splicing in gliomas. Cancer Res. 65:3562–3567. 2005.
|
|
6
|
Song SW, Fuller GN, Khan A, et al: IIp45,
an insulin-like growth factor binding protein 2 (IGFBP-2) binding
protein, antagonizes IGFBP-2 stimulation of glioma cell invasion.
Proc Natl Acad Sci USA. 100:13970–13975. 2003.
|
|
7
|
Wang Y, Wen J and Zhang W: MIIP, a
cytoskeleton regulator that blocks cell migration and invasion,
delays mitosis, and suppresses tumorogenesis. Curr Protein Pept
Sci. 12:68–73. 2011.
|
|
8
|
Munirajan AK, Ando K, Mukai A, et al:
KIF1Bbeta functions as a haploinsufficient tumor suppressor gene
mapped to chromosome 1p36.2 by inducing apoptotic cell death. J
Biol Chem. 283:24426–24434. 2008.
|
|
9
|
Fujita T, Igarashi J, Okawa ER, et al:
CHD5, a tumor suppressor gene deleted from 1p36.31 in
neuroblastomas. J Natl Cancer Inst. 100:940–949. 2008.
|
|
10
|
Ragnarsson G, Eiriksdottir G,
Johannsdottir JT, et al: Loss of heterozygosity at chromosome 1p in
different solid human tumours: association with survival. Br J
Cancer. 79:1468–1474. 1999.
|
|
11
|
Gibbs M, Stanford JL, McIndoe RA, et al:
Evidence for a rare prostate cancer-susceptibility locus at
chromosome 1p36. Am J Hum Genet. 64:776–787. 1999.
|
|
12
|
Yanada M, Yaoi T, Shimada J, et al:
Frequent hemizygous deletion at 1p36 and hypermethylation
downregulate RUNX3 expression in human lung cancer cell lines.
Oncol Rep. 14:817–822. 2005.
|
|
13
|
Ji P, Smith SM, Wang Y, et al: Inhibition
of gliomagenesis and attenuation of mitotic transition by MIIP.
Oncogene. 29:3501–3508. 2010.
|
|
14
|
Shimosato Y: Histological Typing of Lung
and Pleural Tumors (3rd edition, 1999): Malignant epithelial
tumors. Nihon Rinsho. 60(Suppl 5): 123–131. 2002.(In Japanese).
|
|
15
|
Detterbeck FC, Boffa DJ and Tanoue LT: The
new lung cancer staging system. Chest. 136:260–271. 2009.
|
|
16
|
Cunha-Ferreira I, Bento I and
Bettencourt-Dias M: From zero to many: control of centriole number
in development and disease. Traffic. 10:482–498. 2009.
|
|
17
|
Mehlen P and Puisieux A: Metastasis: a
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
|
|
18
|
Wu Y, Song SW, Sun J, et al: IIp45
inhibits cell migration through inhibition of HDAC6. J Biol Chem.
285:3554–3560. 2010.
|
|
19
|
Song F, Ji P, Zheng H, et al: Definition
of a functional single nucleotide polymorphism in the cell
migration inhibitory gene MIIP that affects the risk of breast
cancer. Cancer Res. 70:1024–1032. 2010.
|
